Dopamine receptors–IUPHAR R eview 13 JM Beaulieu, S Espinoza, RR Gainetdinov British journal of pharmacology 172 (1), 1-23, 2015 | 632 | 2015 |
Pronounced hyperactivity, cognitive dysfunctions, and BDNF dysregulation in dopamine transporter knock-out rats D Leo, I Sukhanov, F Zoratto, P Illiano, L Caffino, F Sanna, G Messa, ... Journal of Neuroscience 38 (8), 1959-1972, 2018 | 194 | 2018 |
Functional interaction between trace amine-associated receptor 1 and dopamine D2 receptor S Espinoza, A Salahpour, B Masri, TD Sotnikova, M Messa, LS Barak, ... Molecular pharmacology 80 (3), 416-425, 2011 | 189 | 2011 |
Taar1-mediated modulation of presynaptic dopaminergic neurotransmission: role of D2 dopamine autoreceptors D Leo, L Mus, S Espinoza, MC Hoener, TD Sotnikova, RR Gainetdinov Neuropharmacology 81, 283-291, 2014 | 142 | 2014 |
BRET biosensors to study GPCR biology, pharmacology, and signal transduction A Salahpour, S Espinoza, B Masri, V Lam, LS Barak, RR Gainetdinov Frontiers in endocrinology 3, 105, 2012 | 139 | 2012 |
TAAR1 modulates cortical glutamate NMDA receptor function S Espinoza, G Lignani, L Caffino, S Maggi, I Sukhanov, D Leo, L Mus, ... Neuropsychopharmacology 40 (9), 2217-2227, 2015 | 122 | 2015 |
The dopamine metabolite 3-methoxytyramine is a neuromodulator TD Sotnikova, JM Beaulieu, S Espinoza, B Masri, X Zhang, A Salahpour, ... PloS one 5 (10), e13452, 2010 | 108 | 2010 |
Postsynaptic D2 dopamine receptor supersensitivity in the striatum of mice lacking TAAR1 S Espinoza, V Ghisi, M Emanuele, D Leo, I Sukhanov, TD Sotnikova, ... Neuropharmacology 93, 308-313, 2015 | 102 | 2015 |
Trace amine-associated receptor 1: a multimodal therapeutic target for neuropsychiatric diseases MD Schwartz, JJ Canales, R Zucchi, S Espinoza, I Sukhanov, ... Expert opinion on therapeutic targets 22 (6), 513-526, 2018 | 64 | 2018 |
Insights into the Structure and Pharmacology of the Human Trace Amine‐Associated Receptor 1 (hTAAR1): Homology Modelling and Docking Studies E Cichero, S Espinoza, RR Gainetdinov, L Brasili, P Fossa Chemical biology & drug design 81 (4), 509-516, 2013 | 64 | 2013 |
SINEUP non-coding RNA targeting GDNF rescues motor deficits and neurodegeneration in a mouse model of Parkinson’s disease S Espinoza, M Scarpato, D Damiani, F Managò, M Mereu, A Contestabile, ... Molecular Therapy 28 (2), 642-652, 2020 | 57 | 2020 |
Design, Synthesis, and Evaluation of Thyronamine Analogues as Novel Potent Mouse Trace Amine Associated Receptor 1 (mTAAR1) Agonists G Chiellini, G Nesi, M Digiacomo, R Malvasi, S Espinoza, M Sabatini, ... Journal of Medicinal Chemistry 58 (12), 5096-5107, 2015 | 57 | 2015 |
Trace amine-associated receptor 5 provides olfactory input into limbic brain areas and modulates emotional behaviors and serotonin transmission S Espinoza, I Sukhanov, EV Efimova, A Kozlova, KA Antonova, P Illiano, ... Frontiers in molecular neuroscience 13, 18, 2020 | 54 | 2020 |
Long-term optical stimulation of channelrhodopsin-expressing neurons to study network plasticity G Lignani, E Ferrea, F Difato, J Amarù, E Ferroni, E Lugarà, S Espinoza, ... Frontiers in molecular neuroscience 6, 22, 2013 | 48 | 2013 |
Increased context-dependent conditioning to amphetamine in mice lacking TAAR1 I Sukhanov, L Caffino, EV Efimova, S Espinoza, TD Sotnikova, L Cervo, ... Pharmacological research 103, 206-214, 2016 | 46 | 2016 |
Further Insights Into the Pharmacology of the Human Trace Amine‐Associated Receptors: Discovery of Novel Ligands for TAAR 1 by a Virtual Screening Approach E Cichero, S Espinoza, S Franchini, S Guariento, L Brasili, ... Chemical biology & drug design 84 (6), 712-720, 2014 | 46 | 2014 |
TAAR1-dependent effects of apomorphine in mice I Sukhanov, S Espinoza, DS Yakovlev, MC Hoener, TD Sotnikova, ... International Journal of Neuropsychopharmacology 17 (10), 1683-1693, 2014 | 46 | 2014 |
In-vivo pharmacology of trace-amine associated receptor 1 VM Lam, S Espinoza, AS Gerasimov, RR Gainetdinov, A Salahpour European journal of pharmacology 763, 136-142, 2015 | 43 | 2015 |
Novel biguanide-based derivatives scouted as TAAR1 agonists: Synthesis, biological evaluation, ADME prediction and molecular docking studies M Tonelli, S Espinoza, RR Gainetdinov, E Cichero European Journal of Medicinal Chemistry 127, 781-792, 2017 | 42 | 2017 |
Adenylyl cyclase activating polypeptide reduces phosphorylation and toxicity of the polyglutamine-expanded androgen receptor in spinobulbar muscular atrophy MJ Polanco, S Parodi, D Piol, C Stack, M Chivet, A Contestabile, ... Science Translational Medicine 8 (370), 370ra181-370ra181, 2016 | 42 | 2016 |